CELL-PERMEANT PEPTIDE-BASED INHIBITOR OF KINASES
The described invention provides kinase inhibiting compositions containing a therapeutic amount of a therapeutic inhibitor peptide that inhibits at least one kinase enzyme, methods for treating an inflammatory disorder whose pathophysiology comprises inflammatory cytokine expression, and methods for...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English French |
Published |
18.07.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The described invention provides kinase inhibiting compositions containing a therapeutic amount of a therapeutic inhibitor peptide that inhibits at least one kinase enzyme, methods for treating an inflammatory disorder whose pathophysiology comprises inflammatory cytokine expression, and methods for treating an inflammatory disorder whose pathophysiology comprises inflammatory cytokine expression using the kinase inhibiting compositions.
La présente invention concerne des compositions inhibitrices de kinases contenant une quantité thérapeutique d'un peptide inhibiteur thérapeutique qui inhibe au moins une enzyme kinase, des méthodes de traitement d'un trouble inflammatoire dont la pathophysiologie comprend l'expression d'une cytokine inflammatoire et des méthodes de traitement d'un trouble inflammatoire dont la pathophysiologie comprend l'expression d'une cytokine inflammatoire par l'emploi des compositions inhibitrices de kinases. |
---|---|
Bibliography: | Application Number: CA20092744104 |